Mitsubishi UFJ Trust & Banking’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-206,260
Closed -$842K 1109
2023
Q4
$842K Sell
206,260
-26,570
-11% -$97.9K ﹤0.01% 858
2023
Q3
$901K Sell
232,830
-15,900
-6% -$85.5K ﹤0.01% 838
2023
Q2
$1.48M Buy
248,730
+4,750
+2% +$27.4K ﹤0.01% 798
2023
Q1
$798K Hold
243,980
﹤0.01% 836
2022
Q4
$964K Hold
243,980
﹤0.01% 826
2022
Q3
$1.46M Hold
243,980
﹤0.01% 791
2022
Q2
$1.57M Sell
243,980
-4,910
-2% -$31.3K ﹤0.01% 798
2022
Q1
$2.06M Hold
248,890
﹤0.01% 792
2021
Q4
$3.85M Sell
248,890
-25,770
-9% -$497K 0.01% 759
2021
Q3
$6.18M Sell
274,660
-4,500
-2% -$94.5K 0.01% 709
2021
Q2
$5.49M Buy
279,160
+215,350
+337% +$4.88M 0.01% 740
2021
Q1
$2.14M Buy
+63,810
New +$2.08M ﹤0.01% 789

Other funds holding SANA

Mitsubishi UFJ Trust & Banking's SANA Position: Q1 2024 in Review

Mitsubishi UFJ Trust & Banking sold out of Sana Biotechnology (SANA) in Q1 2024, closing a stake of 206,260 shares — an estimated $842K sold.

Mitsubishi UFJ Trust & Banking first reported a position in SANA in Q1 2021 and held it in 12 quarters. The position peaked at $6.18M in Q3 2021. 154 funds tracked by Wall St. Rank hold SANA as of Q1 2024.

  • Mitsubishi UFJ Trust & Banking reported no remaining Sana Biotechnology position as of Q1 2024 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 206,260 Sana Biotechnology shares in Q1 2024, an estimated $842K.
  • Mitsubishi UFJ Trust & Banking first reported a position in Sana Biotechnology in Q1 2021 and held it in 12 quarters.
  • Mitsubishi UFJ Trust & Banking's Sana Biotechnology position peaked at $6.18M in Q3 2021.
  • 154 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2024.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q1 2024, filed 10 May 2024.